CiVentiChem News and Resources

CDMO News

CiVentiChem Expands Manufacturing Capacity by 300% with New Facility

CiVentiChem, a Contract Development and Manufacturing Organization (CDMO), has completed a new facility that significantly increases its manufacturing capacity by 300%. This expansion is aimed at producing Regulatory Starting Materials (RSMs) and intermediates, supporting both small molecule clinical and commercial

Read More »
Who do you rate?
Recommend a Supplier

Help us find the most innovative and trusted suppliers in Pharma and Biotech.